Johnson & Johnson Requests EUA, FDA Schedules VRBPAC Meeting Date
On Thursday, Johnson & Johnson’s pharmaceutical division Janssen Biotech, Inc. requested from the U.S. Food and Drug Administration (FDA) an emergency use authorization (EUA) for its single-dose COVID-19 vaccine. According to Johnson & Johnson, the COVID-19 vaccine has a 72 percent efficacy rate in the U.S., but only a 57 percent efficacy rate in South…
Read More »